Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Surgery
|
August 1, 1990
Protein-calorie malnutrition inhibits antitumor response to interleukin-2 immunotherapy
M D Lieberman, J Reynolds, J Goldfine, et al.
The Journal of Surgical Research
|
April 1, 1991
Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines
M D Lieberman, R K Sigal, N N Williams, et al.
CA: a Cancer Journal for Clinicians
|
April 2, 1998
Nutritional support of the cancer patient
D E Rivadeneira, D Evoy, T J Fahey, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 1, 1991
Comparison of acute and chronic protein-energy malnutrition on host antitumor immune mechanisms
M D Lieberman, J Reynolds, H P Redmond, et al.
Surgery
|
August 1, 1996
Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines
M D Lieberman, P Paty, X K Li, et al.
The Journal of Surgical Research
|
May 1, 1990
Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model
M D Lieberman, J Shou, R K Sigal, et al.
Cancer Gene Therapy
|
December 23, 1999
Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma
E A Hirschowitz, H A Naama, D Evoy, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
May 1, 1991
Dietary manipulation of methotrexate-induced enterocolitis
J Shou, M D Lieberman, K Hofmann, et al.
Journal of Pediatric Surgery
|
April 1, 1991
Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy
R K Sigal, M D Lieberman, J V Reynolds, et al.
Surgery
|
July 1, 1992
Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome
J M Daly, M D Lieberman, J Goldfine, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Surgery
|
August 1, 1990
Protein-calorie malnutrition inhibits antitumor response to interleukin-2 immunotherapy
M D Lieberman, J Reynolds, J Goldfine, et al.
The Journal of Surgical Research
|
April 1, 1991
Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines
M D Lieberman, R K Sigal, N N Williams, et al.
CA: a Cancer Journal for Clinicians
|
April 2, 1998
Nutritional support of the cancer patient
D E Rivadeneira, D Evoy, T J Fahey, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
January 1, 1991
Comparison of acute and chronic protein-energy malnutrition on host antitumor immune mechanisms
M D Lieberman, J Reynolds, H P Redmond, et al.
Surgery
|
August 1, 1996
Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines
M D Lieberman, P Paty, X K Li, et al.
The Journal of Surgical Research
|
May 1, 1990
Transfusion-induced immunosuppression results in diminished host survival in a murine neuroblastoma model
M D Lieberman, J Shou, R K Sigal, et al.
Cancer Gene Therapy
|
December 23, 1999
Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma
E A Hirschowitz, H A Naama, D Evoy, et al.
JPEN. Journal of Parenteral and Enteral Nutrition
|
May 1, 1991
Dietary manipulation of methotrexate-induced enterocolitis
J Shou, M D Lieberman, K Hofmann, et al.
Journal of Pediatric Surgery
|
April 1, 1991
Low-dose interferon gamma renders neuroblastoma more susceptible to interleukin-2 immunotherapy
R K Sigal, M D Lieberman, J V Reynolds, et al.
Surgery
|
July 1, 1992
Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome
J M Daly, M D Lieberman, J Goldfine, et al.
Page
of 3